May 1, 2026: Study Links Ozempic (Semaglutide), Other GLP-1s To Hair Loss Risk A systemic review of 24 studies found evidence that the use of certain GLP-1s, including semaglutide (Ozempic), may increase risk of hair loss in patients
Vitamin C & E Protect skin from environmental damage
The key concern is that people who start GLP-1 medications may differ in important ways from people starting other diabetes drugs. People who are starting GLP-1s could be more motivated to change their behaviors, be more engaged with their health care or receive more intensive follow-up from clinicians, Alexander said
You can change your weekly injection day as long as at least 3 days (72 hours) have passed since the last dose
Post-injection inflammation can be managed at home with symptomatic relief
If the gastrointestinal effects of semaglutide are a dealbreaker, sermorelin offers a dramatically gentler experience